Three novel 6-methyl-2-oxo-quinoline-3-carbaldehyde thiosemicarbazone (H-L) transition metal 
Introduction
Over the past three decades, inspired by the success of cisplatin and related platinum complexes as anticancer agents, [1] [2] [3] researchers have actively explored transition metal complexes to search for novel compounds with better medicinal activity. Many organic ligands that exhibit good antitumor activity have been designed and combined with transition metals to give novel complexes as anticancer drugs. In our previous work, synthetic heterocyclic compounds that are active ingredients in traditional Chinese medicines were employed as organic ligands to successfully produce new transition metal complexes that possessed stronger anticancer activities.
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The anticancer activities of quinoline and its derivatives have been intensively studied in drug discovery and development.
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2-Oxo-quinoline is a quinoline alkaloid that is widely found in nature. Some synthetic derivatives of 2-oxo-quinoline were found to exhibit superior anticancer activity. [12] [13] [14] Besides, thiosemicarbazones and their metal complexes also possess good antitumor activities. [15] [16] [17] [18] Nevertheless, to the best of our knowledge, the transition metal complexes of thiosemicarbazones derived from 6-methyl-2-oxo-quinoline-3-carbaldehyde have not been examined as potential anticancer agents.
In this work, we choose the biocompatible endogenous metal ions such as Cu(II), Zn(II) and Co(II) which play essential role in biological living system. Zinc has an important role in various biological systems, 19 since it is critical for numerous cell processes and is a major regulatory ion in the metabolism of cells. 20 In the literature, diverse zinc complexes with biological activity are reported. More specically, crystal structures of zinc complexes with drugs used for the treatment of Alzheimer disease 21 or presenting anticonvulsant, 22 antidiabetic, 23 antiinammatory, 24 antimicrobial, 25 antiproliferative or antitumor [26] [27] [28] and bactericidal 29 activity are now available. In addition, some Co(II) complexes exhibit interesting biological activity such as antifungal antibacterial and anticancer activity. For instance, Co(II) complexes of acyl-hydrazones are known for wide spectrum of biological and pharmaceutical activities, such as inhibition of tumor growth, 30, 31 antioxidative effect, 32 antimicrobial and antiviral. 33 In the previous literature, a number of Cu(II) complexes with biological activities such as antibacterial and anti-cancer properties have been also reported. 34, 35 In the present work, we synthesized and characterized three transition metal complexes of 6-methyl-2-oxo-quinoline-3-carbaldehyde thiosemicarbazone (H-L), and we measured their in vitro cytotoxicities against ve tumor cell lines. The mechanism of their interaction with DNA was also examined.
Experimental

Materials
All chemical reagents, including nitrate salts and solvents, were of analytical grade. The ligand H-L was synthesized according to the literature. 36 Ethidium bromide (EB) was purchased from Biotium (ShangHai, China). Calf thymus DNA (ct-DNA) was purchased from Sigma-Aldrich. The pBR322 plasmid DNA was purchased from TaKaRa Biotech. All materials were used as received without further purication unless noted otherwise. The synthetic complexes were dissolved in dimethyl sulfoxide (DMSO) as a stock solution (2.0 mM) for DNA binding studies. The TBS buffer (5 mM Tris, 50 mM NaCl, adjusted to pH ¼ 7.3 with hydrochloric acid) was prepared using double distilled water. A TBS solution of the ct-DNA gave a ratio of UV absorbance at 260-280 nm of ca. 1.85 : 1, indicating that the DNA was sufficiently free of protein. The DNA concentration per nucleotide was determined spectrophotometrically by employing a molar absorption coefficient of 6600 M À1 cm À1 at 260 nm.
Instrumentation
Elemental analyses (C, H, N) were carried out on a Perkin Elmer Series II CHNS/O 2400 elemental analyzer. NMR spectra were recorded on a Bruker AV-500 NMR spectrometer. Fluorescence measurements were performed on a Shimadzu RF-5301/PC spectrouorophotometer. The circular dichroism (CD) spectra of the DNA were obtained at 25 C on a JASCO J-810 spectropolarimeter. The region between 200 and 400 nm was scanned for each sample. The UV-Vis spectra were recorded on a TU-1901 ultraviolet spectrophotometer. 
Synthesis of complex 1
X-ray crystallography
The blue block crystal of complex 1 (0.21 Â 0.14 Â 0.07 mm) was measured on a Bruker Smart Apex II or a Rigaku Saturn CCD diffractometer with graphite monochromatic Mo-Ka
The yellow block crystal of complex 2 (0.17 Â 0.08 Â 0.06 mm) was measured on a Bruker Smart Apex II or a Rigaku Saturn CCD diffractometer with graphite monochromatic Mo-Ka radiation (l ¼ 0.71074 A) at 298(2) K, 3.1 < q < 25.7 for hkl (À10 # h # 8, À11 # k # 11, À14 # l # 14) in the triclinic lattice. The positions and anisotropic thermal parameters of all nonhydrogen atoms were rened on F 2 by full-matrix leastsquares techniques with the SHELX-97 program package.
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Absorption correction was conducted with semi-empirical methods from equivalents.
In vitro cytotoxicity
The BEL-7404, Hep-G2, SK-OV-3, MGC80-3 and HeLa cancer cell lines and the normal liver cell HL-7702 were obtained from the Shanghai Cell Bank in the Chinese Academy of Sciences. Cell lines were grown in triplicate in 96-well plates (Gibco, UK) and incubated for 48 h at 37 C in a humidied atmosphere containing 5% CO 2 and 95% air. To investigate the potential activity of complexes 1-3, cisplatin was employed as a reference metallodrug. Cytotoxicity assays were carried out in 96-well, at bottomed microtitre plates. Specically, the supplemented culture medium with cell lines was added to the wells. Complexes 1-3 and cisplatin were dissolved in the culture medium at various concentrations (1.25, 2.5, 5.0, 10.0 and 20.0 mM) with 1% DMSO, and the resulting solutions were subsequently added to a set of wells. The control wells contained supplemented medium with 1% DMSO. The microtitre plates were then incubated at 37 C in a humidied atmosphere containing 5% CO 2 and 95% air for 2 days. Cytotoxic screening through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was conducted. At the end of each incubation period, the MTT solution (10 mL, 5 mg mL À1 ) was added into each well and the cultures were incubated for a further 48 h (the treatment times were 24, 48 and 72 h for time-dependent cytotoxicity studies) at 37 C in a humidied atmosphere containing 5% CO 2 and 95% air. Aer removal of the supernatant, DMSO (150 mL) was added to dissolve the formazan crystals. The absorbance at 570 and 630 nm was read from an enzyme labeling instrument. Cytotoxicity was estimated based on the percentage cell survival in a dosedependent manner relative to the negative control. The nal IC 50 values were calculated by the Bliss method (n ¼ 5). All tests were repeated in at least three independent experiments.
Spectroscopic studies on DNA interaction
The stock solution of ct-DNA (2 Â 10 À3 M) was stored at 4 C for no more than 5 days before use. For DNA binding studies, stock solutions of the synthesized complexes 1-3 in DMSO (2.0 mM) were diluted with TBS (at $11.5 : 1 v/v) to give the nal working solutions that contained no more than 8% DMSO. For the UVVis absorption experiments, the stock solutions of 1-3 (2.0 mM in DMSO) were used directly as the working solutions.
Increasing amounts of the ct-DNA stock solution were added until saturation was achieved, and the solution was allowed to incubate for 5 min aer each addition before the absorption spectra were recorded. The intrinsic binding constant K b was determined by the equation: 
, where F 0 and F are the peak emission intensities of the EB-DNA system in the absence and presence of each complex as the quencher, and [Q] is the concentration of the quencher. The CD absorption spectra of the DNA in TBS were measured at 100 nm min À1 scan rate over 200-400 nm, with 1 Â 10 À4 M DNA in the absence and presence of each compound at various concentrations. The CD signal of TBS was taken as the background and subtracted from the spectra. All spectroscopic experiments were performed at 25 C.
Agarose gel electrophoresis assay
For plasmid DNA unwinding experiments, the stock solutions of all complexes (2.0 mM in DMSO) were diluted with TBE buffer (Tris/boric acid/EDTA buffer solution) to 20-100 mM. The complexes at designated concentrations were mixed with 0.5 mg DNA and diluted to 25 mL with TBE buffer so that electrophoresis on each sample could be conducted twice. All samples were incubated at 25 C in dark for 4 h. Each sample (12 mL) was then mixed with DNA loading buffer (2 mL) and underwent electrophoresis on 0.8% agarose gel immersed in TBE buffer for 90 min at 5 V cm À1 , followed by visualization on a BIO-RAD imaging system with a UV-Vis transilluminator.
Apoptosis assays by ow cytometry
Phosphate buffered saline (PBS) solution (2 mmol KH 2 PO 4 , 10 mmol Na 2 HPO 4 , 136.7 mmol NaCl, 2.68 mmol KCl, adjusted to pH ¼ 7.4 with hydrochloric acid) was prepared using double distilled water (adjusted to a volume of 1000 mL). The ability of complex 1 to induce apoptosis was evaluated by ow cytometry of a MGC80-3 cell line with annexin V-FITC and PI counterstaining. MGC80-3 cells undergoing exponential growth were inoculated in six-well plates and cultured for 24 h before complex 1 was added at designated nal concentrations. Aer incubation for 24 h, the cells were harvested, washed twice in PBS, and resuspended in 100 mL binding buffer
at a concentration of 1 Â 10 6 cells per mL. The cells were then incubated with 5 mL annexin V-FITC (in a buffer containing 10 mmol L À1 NaCl, 1% bovine serum albumin, 0.02% NaN 3 , and 50 mmol L À1 Tris, pH 7.4) and 10 mL PI (20 mg mL À1 ) for 15 min at room temperature in dark. Cells were protected from light before analysis by ow cytometry on a Becton Dickinson FACSCalibur analyzer.
Cell cycle analysis
The MGC80-3 cells were maintained in Dulbecco's modied Eagle's medium with 10% fetal calf serum in 5% CO 2 at 37 C. 
Other experimental methods
The ESI † provides the detailed procedures of other experimental methods, including the measurement of mitochondrial membrane potential (by JC-1 staining), ROS generation, intracellular free Ca 2+ , Western blot, and caspase-3/9 activity. The procedures were similar to those given in the previous work of Chen et al.
Results and discussion
Chemistry
Complexes 1-3 were synthesized as outlined in Scheme 1. The 6-methyl-2-oxo-quinoline-3-carbaldehyde thiosemicarbazone (H-L) was obtained from 4-methyl-acetanilide in good yield through the Vilsmeier-Haack-Arnold reaction, hydrolysis and condensation.
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Crystal structure of complexes 1 and 2
Complexes 1 and 2 both had a mononuclear structure. Fig. 1 shows the structure of 1 and Table S2 † lists the selected bond lengths and angles. The coordination of the thiosemicarbazone with Cu(II) resulted in the formation of six-membered (CuNCCCO) and ve-membered (CuNNCS) chelating rings.
Moreover, one NO 3 À group took part in coordination. Fig. 2 shows the structure of complex 2 and 
Stability in solution
The stability of complexes 1-3 in physiological condition (PBS buffer solution containing 1% DMSO, pH 7.35) was tested by UV-Vis spectroscopy (Fig. S1 †) . Fig. S1 † shows the timedependent (0, 1, 4, 12, 24 and 48 h) UV-Vis spectra of each complex. No obvious changes could be found in the spectral character and the peak absorptions of 1-3 over time, suggesting that they were also stable in their coordinating mode in the aqueous solution. Besides, in the ESI-MS analysis (Fig. S14 †) Cisplatin was used as the positive control. Table S4 † lists the inhibitory rates. It was found that 1-3 showed higher inhibitory activity than the free ligand H-L against the SK-OV-3, BEL-7404, HeLa, Hep-G2 and MGC80-3 cell lines. Moreover, both H-L and the complexes 1-3 displayed lower inhibitory rates against normal liver cells (HL-7702) than the commercial anticancer drug cisplatin. The in vitro cytotoxicity of H-L and complexes 1-3 were further quantied by determining their corresponding IC 50 values. Table 1 showed that, toward the tested human tumor cells, complexes 1-3 had much stronger cytotoxicity than 
Cell cycle analysis
Since complexes 1-3 had IC 50 values in the low micromolar range, experiments were then carried out to determine the phase of the cell cycle in which these compounds arrested cell growth. The DNA content of cells was estimated by ow cytometry aer the cells were stained with propidium iodide (PI). Fig. 3 shows the ow cytometry data of the MGC80-3 cells treated with complex 1, together with the control data. The proportion of MGC80-3 cells in the S phase was 27.02% in the control, but increased to 38.31% aer the cells were treated with 1. Therefore, complex 1 could arrest the MGC80-3 cells in the S phase.
Apoptosis assays
It is known that apoptosis assays can provide important information on the preliminary mode of action. To determine whether the observed death of the MGC80-3 cells induced by complex 1 resulted from apoptosis or necrosis, common biochemical markers of apoptosis were monitored, including mitochondrial membrane depolarization, chromatin condensation, and phosphatidylserine exposure. Cells were subjected to annexin V-FITC and PI staining, and classied as necrotic (Q1; annexin À /PI + ), late apoptotic (Q2; annexin + /PI + ), intact (Q3; annexin À /PI À ), or early apoptotic (Q4; annexin + /PI À ). Fig. 4 shows the assay results. The proportions of late (Q2) and early (Q4) apoptotic cells aer treatment with 1 for 24 h amounted to 12.1% and 53.9%, respectively, and the total apoptosis rate (including early and late apoptosis ratios) was 66%. The results from annexin V staining and ow cytometry suggested that complex 1 (10 mM) induced the apoptotic death of MGC80-3 cells. Similarly, the apoptosis rate of MGC80-3 cell aer treatment with 2 (10 mM), 3 (10 mM), and cisplatin (10 mM) for 24 h were found to be 2.65%, 4.11% and 14.19%, respectively.
DNA binding studies
Although there are other biological targets in tumor cells, including RNA, enzymes and proteins, it is widely believed that DNA is the primary target for many anticancer drugs.
42,43
Consequently, the interactions between the small molecules and the DNA play a pivotal role in the drug's antitumor activity.
To examine the DNA binding properties of complexes 1-3, UVVis, uorescence and CD spectra were recorded, and gel mobility shi assays were performed. 3.7.1. UV-Vis absorption analysis. UV-Vis absorption spectroscopy is considered to be one of the most useful techniques for studying the binding mode of metal complexes with DNA, 44, 45 and it was applied to assess the interaction between complexes 1-3 and ct-DNA. Fig. 5 shows the UV-Vis absorption spectra of complexes 1-3 in the absence and presence of ct-DNA. In the presence of ct-DNA, the absorption bands of complex 1 at 242, 270, and 380 nm exhibited hypochromism of about 31.08%, 29.79% and 18.10%, respectively, whereas for complex 2 the bands at 242, 350 and 383 nm exhibited 
Fluorescence emission titration.
The binding modes of these complexes with ct-DNA were further monitored by a competitive binding assay, in which they acted as an intercalative binding probe to compete with ethidium bromide (EB). EB is well known as a highly sensitive dye that emits intense uorescence upon its strong, non-specic intercalation between DNA base pairs. 46 Competitive binding of other molecules to DNA can replace the bound EB and reduce the uorescence intensity. Therefore, this uorescence-based competition technique provides indirect evidence for the DNA binding mode. shows the emission spectra of the EB-ct-DNA system in the absence and presence of 1-3. When the concentration of complex increased, the characteristic emission of EB at around 580 nm was strongly quenched, and the emission of other bands (around 470 nm) gradually strengthened. Therefore, these three complexes could displace EB from the DNA-EB system, implying that their intercalative binding mode to DNA was similar to that of EB. The total decrease ratios (TDR) of the EB emission intensity for complexes 1, 2 and 3 were found to be 79.49%, 36.96%, and 87.02%, respectively, and the corresponding decrease ratios (DR respectively. The K q values quantied the quenching ability of the complexes and were in agreement with K b values determined from the UV-Vis absorption spectra. 3.7.3. Circular dichroism spectra. Circular dichroism (CD) spectroscopy is a rapid and useful technique to estimate whether nucleic acids have undergone conformational transformation as a result of complex formation or changes in environmental conditions. 48 The CD spectroscopy was employed to further assess the interaction between the complexes (1-3) and ct-DNA. As shown in Fig. 7 , the CD spectra of ct-DNA (1 Â 10 À4 M) displayed a positive absorption peak at 277 nm and a negative absorption peak at 243 nm due to p-p base stacking and righthand helicity, respectively, which were in good agreement with the characteristic B conformation of DNA. 49 Upon the addition of complexes 1-3 at 1 : 15 [complex]/[DNA] ratio, the CD absorption of ct-DNA showed an obvious decrease in the intensity of the positive band. The positive band showed an obvious blue-shi when 1 was added but showed a red-shi when 2 was added, and the red-shi became even more pronounced when 3 was added. The negative band displayed a clear red-shi in all cases, and the intensity of the band decreased markedly aer the addition of 1 or 2. Note that upon continued addition of 1-3, both the hypochromism and the red/blue-shi in the CD absorption spectra intensied, and even the shapes of the ct-DNA absorption curves changed markedly (Fig. 7) . The results suggested that 1-3 could intercalate between the adjacent base pairs of ct-DNA, since the decrease in the intensity of positive and negative bands in the CD absorption of ct-DNA is usually observed upon the intercalative binding of small molecules to DNA. 50 Furthermore, the appreciable red/blue-shis and the marked changes in the shape of the ct-DNA absorption curve indicated that the secondary structure of the ct-DNA underwent signicant transformations. 51 3.7.4. Agarose gel electrophoresis assay. The binding modes of 1-3 to DNA were further investigated by agarose gel electrophoresis assay. The pBR322 plasmid DNA was used to displace ct-DNA, and EB and cisplatin were used as references. When its concentration increased from 20 to 60 mM, EB signi-cantly decreased the electrophoretic mobility of the supercoiled conformation (Form I) of pBR322 DNA (Fig. S16 †) . Under the same condition, cisplatin did not affect the electrophoretic mobility. However, Fig. 8 shows that as the concentration of 1-3 increased, not only the major form of DNA (supercoiled, Form I) but also the minor forms of DNA (nicked, Form II; linear, Form III) underwent signicant changes in migration rate and proportions. It could thus be inferred that 1-3 intercalated to the DNA between neighboring base pairs. 52, 53 Note that intercalation of complex 1 to the DNA was stronger than that of EB and cisplatin. 54, 55 Even at a low concentration of 20 mM, complex 1 clearly decreased the migration rate of the supercoiled form of the DNA, indicating that the extent of intercalation between neighboring base pairs was high. In addition, when the concentration of complex 2 was 60 mM, the Form III of pBR322 DNA disappeared completely, and the proportion of Form II DNA decreased. Upon the addition of complex 3, the proportions of all three forms of pBR322 DNA decreased, and the Form II DNA disappeared completely when the concentration of 3 reached 40 mM. These ndings were consistent with the results of the UV-Vis absorption analysis, uorescence spectral analysis, and circular dichroism experiment.
Taken together, it could be inferred that intercalation through the aromatic planar structure of the 6-methyl-2-oxoquinoline-3-carbaldehyde thiosemicarbazone ligand is the most probable binding mode between the complexes 1-3 and DNA. Since complex 1 gave the highest apoptosis rate in MGC80-3 cells, it was examined in additional cellular tests, including the loss of mitochondrial membrane potential (Dj), intracellular Ca 2+ uctuation, expressions of apoptotic related proteins, reactive oxygen species (ROS) level, caspase-3/9 activation, and Western blot assay.
Loss of mitochondrial membrane potential in MGC80-3 cells
The loss of mitochondrial membrane potential (Dj) or mitochondrial dysfunction is involved in apoptotic cell death due to the cytotoxicity of the antitumor target compound. 56,57 Fig. 9 shows the changes in Dj induced by the copper complex 1. JC-1 staining was used as a uorescent probe. Aer the MGC80-3 cells were treated with the copper complex 1 (10 mM) for 24 h, the Dj decreased signicantly. Therefore, the induction of apoptosis by complex 1 was associated with the intrinsic (mitochondrial) pathway. 40, 56, 57 3.9. Intracellular Ca 2+ The increase in Ca 2+ level mediated by various channels can alter the mitochondrial membrane potential Dj, and thus has been recognized as a factor in cell death, cell apoptosis, and cell injury. 40, 58 With this in mind, we examined the effects of the copper complex 1 on the mobilization of intracellular Ca 2+ in MGC80-3 cells. Fig. 10 shows that the level of intracellular free Ca 2+ in the MGC80-3 cells was the lowest in the control group but increased steadily upon addition of complex 1 (10 mM). Therefore, the changes in intracellular Ca 2+ level may be involved in the mechanism by which complex 1 induced apoptosis in MGC80-3 cells.
Expressions of apoptotic related proteins
To further study the mechanism of action of complex 1, the proteins in the mitochondria-related apoptotic pathway, including cytochrome c (Cyt C), bcl-2, bax and apaf-1, were investigated by Western blot. 59 Fig. 11 shows that aer the MGC80-3 cells were treated with complex 1 (10 mM and 20 mM) for 24 h, the levels of apaf-1, Cyt C, and bax proteins increased signicantly and the level of bcl-2 protein decreased signicantly. These results further demonstrated that complex 1 may be involved in mitochondria-related apoptosis. 59 
Reactive oxygen species (ROS) level
It has been reported that the disregulation of ROS generation could dramatically affect cancer cell structure and might result in cell damage, and consequently cell death and apoptosis. 60, 61 The ROS generation in MGC80-3 cells treated with complex 1 (10 mM) for 24 h was measured by a uorescent marker to determine whether the apoptosis or death of MGC80-3 cells induced by the copper complex 1 (10 mM) depended on the ROS level. Fig. 12 shows that the MGC80-3 cells treated with the copper complex 1 (10 mM) produced high levels of ROS compared with the control MGC80-3 cells. Therefore, the copper complex 1 (10 mM) stimulated ROS-induced apoptosis in MGC80-3 cells.
Assessment of caspase-3/9 activation
The protein extracts of the MGC80-3 cells treated with the copper complex 1 (10 mM and 20 mM) for 24 h were analyzed by ow cytometry to determine if caspase-3 and caspase-9 were involved in the induced apoptotic cell death. Fig. 13 shows additional peaks of activated caspase-3 (FITC-DEVD-FMK probes) and activated caspase-9 (FITC-LEHD-FMK probes) for the treated cells. Notably, aer treatment with 10 mM and 20 mM copper complex 1, the proportion of cells with activated caspase-3 arrived at 34.50% and 45.90%, and the proportion of cells with activated caspase-9 arrived at 16.50% and 26.20%, respectively. Therefore, the copper complex 1 could induce cell apoptosis by triggering the caspase-3/9 activity in MGC80-3 cells.
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Taken together, the copper complex 1 most likely induced apoptosis in MGC80-3 cells by disrupting mitochondrial function, which led to signicantly decreased level of the bcl-2 protein and the loss of Dj, as well as the signicant increase in the ROS level, intracellular Ca 2+ , cytochrome c, apaf-1, activated caspase-3, and activated caspase-9 in MGC80-3 cells.
Conclusions
Three transition metal complexes of 6-methyl-2-oxo-quinoline-3-carbaldehyde thiosemicarbazone were synthesized and characterized by NMR, MS, elemental analyses, as well as X-ray single crystal diffraction. 50 values of complex 1 against SKOV-3 and MGC80-3 were even lower than those of cisplatin. Complex 1 could induce apoptosis of MGC80-3 cells and cause cell arrest in the S phase. These complexes most probably interacted with DNA through intercalation. Moreover, it was found that complex 1 induced MGC80-3 cell apoptosis via a mitochondrial dysfunction pathway. Fig. 12 The ROS generation assay by flow cytometric analysis of MGC80-3 cells treated with the copper complex 1 (10 mM). Results are expressed as relative fluorescent intensities (from left to right). Fig. 13 The activation of caspase-3 and caspase-9 in MGC80-3 cells treated with the copper complex 1 (10 mM and 20 mM) for 24 h, respectively.
